Comparison of Breast MR Imaging with Molecular Breast Imaging in Breast Cancer Screening, Diagnosis, Staging, and Treatment Response Evaluation

Magn Reson Imaging Clin N Am. 2018 May;26(2):273-280. doi: 10.1016/j.mric.2017.12.009.

Abstract

Breast MR imaging and molecular breast imaging (MBI) are functional imaging modalities that can be used to noninvasively evaluate the pathophysiology and biology of breast cancer. In the era of personalized medicine, these imaging techniques give clinicians insight into cancer pathobiology and allows them to individualize treatment regimens. Breast MR imaging has gained acceptance for breast cancer evaluation; work is ongoing on validation of MBI for breast cancer evaluation. This article discusses clinical applications of breast MR imaging and MBI, and compares the performance of these techniques in breast cancer screening, diagnosis, staging, and treatment response evaluation.

Keywords: BSGI; Breast cancer; Breast cancer screening; Breast cancer staging; Breast imaging; Functional imaging; MBI; Neoadjuvant chemotherapy response.

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Breast / diagnostic imaging
  • Breast Neoplasms / diagnostic imaging*
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / pathology*
  • Female
  • Humans
  • Magnetic Resonance Imaging / methods*
  • Molecular Imaging / methods*
  • Neoadjuvant Therapy / methods*
  • Neoplasm Staging
  • Reproducibility of Results
  • Treatment Outcome